The role of endothelin-1 and endothelin receptor antagonists in prostate cancer

BJU International, Supplement

Volumn 85, Issue 2, 2000, Pages 45-48

  Nelson, J B ^a,b   Carducci, M A ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIN 1; ENDOTHELIN A RECEPTOR; ENDOTHELIN B RECEPTOR; ENDOTHELIN RECEPTOR; ENDOTHELIN RECEPTOR ANTAGONIST;

CANCER CELL; CELL PROLIFERATION; HUMAN; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; REVIEW;

EID: 0034071678     PISSN: 14655101     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-410x.2000.00063.x     Document Type: Review

References (52)

1. 1 Landis SH, Murray T, Bolden S et al. Cancer statistics 1998. CA Cancer J Clin 1998; 48: 6-29
2. 2 Huggins C, Hodges CV. Studies on prostatic cancer: I. The effects of castration, of estrogen and androgen injection on serum phosphatases in metastatic carcinoma of the prostate. Cancer Res 1941; 1: 293-303
3. 3 Huggins C, Stevens RE, Hodges CV. Studies on prostatic cancer: II. The effects of castration on advanced carcinoma of the prostate gland. Arch Surg 1941; 43: 209-23
4. 4 Kozlowski JM, Grayhack JT. Carcinoma of the prostate. In Gillenwater JY, Grayhack JT, Howards SS, Duckett JW, eds, Adult and Pediatric Urology. St Louis: Mosby-Year Book, 1991: 1277-393
5. 5 Nelson JB. Alternatives to death: understanding androgen independent prostate cancer. Nature Med 1998; 4: 1011-2
6. 6 Yanagisawa M, Kurihara H, Kimura S et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988; 332: 411-5
7. 7 Inoue A, Yanagisawa M, Kimura S et al. The human endothelin family: three structurally and pharmacologically distinct isopeptides predicted by three separate genes. Proc Natl Acad Sci USA 1989; 86: 2863-7
8. 8 Takasaki C, Yanagisawa M, Kimura S et al. Similarity of endothelin to snake venom toxin. Nature 1988; 335: 303
9. 9 Kochva E, Viljoen CC, Botes DP. A new type of toxin in the venom of snakes of the genus Atractaspis (Atractaspidinae). Toxicon 1982; 20: 581-92
10. 10 Kochva E, Bdolah A, Wollberg Z. Sarafotoxins and endothelins: evolution, structure and function. Toxicon 1993; 31: 541-68
11. 11 Huggins SP, Pelton JT, Miller RC. The structure and specificity of endothelin receptors: their importance in physiology and medicine. Pharmac Ther 1993; 59: 55-123
12. 12 Rubanyi GM, Polokoff MA. Endothelins: molecular biology, biochemistry, pharmacology, physiology, and pathophysiology. Pharmacol Rev 1994; 46: 325-415
13. 13 Langenstroer P, Tang R, Shapiro E et al. Endothelin-1 in the human prostate: tissue levels, source of production and isometric tension studies. J Urol 1993; 149: 495-9
14. 14 Casey ML, Byrd W, MacDonald PC. Massive amounts of immunoreactive endothelin in human seminal fluid. J Clin Endocrinol Metabol 1992; 74: 223-5
15. 15 Walden PD, Ittmann M, Monaco ME et al. Endothelin-1 production and agonist activities in cultured prostate-derived cells: implications for regulation of endothelin bioactivity and bioavailability in prostatic hyperplasia. Prostate 1998; 34: 241
16. 16 Kobayashi S, Tang R, Wang B et al. Binding and functional properties of endothelin receptor subtypes in the human prostate. Mol Pharmacol 1994; 45: 306-11
17. 17 Kobayashi S, Tang R, Wang B et al Localization of endothelin receptors in the human prostate. J Urol 1994; 151: 763-6
18. 18 Galetti TP, Rossi GP, Belloni A et al. Localization of endothelin receptors A and B in normal human prostate and BPH. J Urol 1996; 155: 463A
19. 19 Le Brun G, Moldovan F, Aubin P et al. Identification of endothelin receptors in normal and hyperplastic human prostate tissues. Prostate 1996; 28: 379-84
20. 20 Webb ML, Chao C-C, Rizzo M et al. Cloning and expression of an endothelin receptor subtype B from human prostate that mediates contraction. Mol Pharmacol 1995; 47: 730-7
21. 21 Kondo S, Morita T, Tashima Y. Endothelin receptor density in human hypertrophic and non-hypertrophic prostate tissue. Tohoku J Exp Med 1994; 172: 381-4
22. 22 Nelson JB, Hedican SP, George DJ et al. Identification of endothelin-1 in the pathophysiology of metastatic adenocarcinoma of the prostate. Nature Med 1995; 1: 944-9
23. 23 Nelson JB, Chan-Tack K, Hedican SP et al. Endothelin-1 production and decreased endothelin B receptor expression in advanced prostate cancer. Cancer Res 1996; 56: 663-8
24. 24 Hsu J-Y, Pfahl M. ET-1 expression and growth inhibition of prostate cancer cells: a retinoid target with novel specificity. Cancer Res 1998; 58: 4817-22
25. 25 Battistini B, Chailler P, D'Orleans-Juste P et al. Growth regulatory properties of endothelins. Peptides 1993; 14: 385-99
26. 26 Daub H, Weiss FU, Wallasch C et al. Role of transactivation of the EGF receptor in signaling by G-protein-coupled receptors. Nature 1996; 379: 557-60
27. 27 Wasilenko WJ, Cooper J, Palad AJ et al. Calcium signaling in prostate cancer cells: evidence for multiple receptors and enhanced sensitivity to bombesin/GRP. Prostate 1997; 30: 167-73
28. B receptors in rats. Biochem Biophys Res Comm 1994; 199: 1461-5
29. 29 Yohn JJ, Smith C, Stevens T et al. Autoregulation of endothelin-1 secretion by cultured human keratinocytes via the endothelin B receptor. Biochim Biophys Acta 1994; 1224: 454-8
30. 30 Aria H, Nakao K, Takaya K et al. The human endothelin-B receptor gene: structural organization and chromosomal assignment. J Biol Chem 1993; 268: 3463-70
31. 31 Antequera F, Boyes B, Bird AP. High levels of de novo methylation and altered chromatin structure at CpG islands in cell lines. Cell 1990; 62: 503-14
32. 32 Lee W-H, Morton RA, Epstein JI et al. Cytidine methylation of regulatory sequences near the π-class glutathione S-transferase gene accompanies human prostatic carcinogenesis. Proc Natl Acad Sci USA 1994; 91: 11733-7
33. 33 Baylin SB, Makos M, Wu JJ et al. Abnormal pattern of DNA methylation in human neoplasia: potential consequences for tumor progression. Cancer Cells 1991; 3: 383-90
34. 34 Jones PA. DNA methylation errors and cancer. Cancer Res 1996; 56: 2463-7
35. 35 Nelson JB, Lee W-H, Nguyen SH et al. Methylation of the 5' CpG island of the endothelin B receptor gene is common in human prostate cancer. Cancer Res 1997; 57: 35-7
36. 36 Suzuki N, Matsumoto H, Kitada C et al. Production of endothelin-1 and big-endothelin-1 by tumor cells with epithelial-like morphology. J Biochem 1989; 106: 736-41
37. 37 Kusuhara M, Yamaguchi K, Nagasaki K et al. Production of endothelin in human cancer cell lines. Cancer Res 1990; 50: 3257-61
38. 38 Schrey MP, Patel KV, Tezapsidis N. Bombesin and glucocorticoids stimulate human breast cancer cells to produce endothelin, a paracrine mitogen for breast stromal cells. Cancer Res 1992; 52: 1786-90
39. 39 Economos K, Macdonald PC, Casey ML. Endothelin-1 gene expression and biosynthesis in human endometrial HEC-1A cancer cells. Cancer Res 1992; 52: 554-7
40. 40 Yamashita J, Ogawa M, Nomura K et al. Interleukin 6 stimulates the production of immunoreactive endothelin 1 in human breast cancer cells. Cancer Res 1993; 53: 464-7
41. 41 Yamashita J, Ogawa M, Egami H et al. Abundant expression of immunoreactive endothelin-1 in mammary phyllodes tumor: possible role of endothelin 1 in the growth of stromal cells in phyllodes tumor. Cancer Res 1992; 52: 4046-9
42. 2+ from extra-and intracellular pools in osteoblastic cells. Am J Physiol 1989; 257: E797-803
43. 43 Takuwa Y, Masaki T, Yamashita K. The effects of the endothelin family peptides on cultured osteoblastic cells from rat calvariae. Biochem Biophys Res Comm 1990; 170: 998-1005
44. 44 Shioide M, Noda M. Endothelin modulates osteopontin and osteocalcin messenger ribonucleic acid expression in rat osteoblastic osteosarcoma cells. J Cell Biochem 1993; 53: 176-80
45. 45 Alam ASMT, Gallagher A, Shankar V et al. Endothelin inhibits osteoclastic bone resorption by a direct effect on cell motility: implications for the vascular control of bone resorption. Endocrinology 1992; 130: 3617-24
46. 46 Reddi AH, Huggins C. Biochemical sequences in the transformation of normal fibroblasts in adolescent rats. Proc Nat Acad Sci USA 1972; 69: 1601-5
47. 47 Reddi AH, Sullivan NE. Matrix-induced endochondral bone differentiation influence of hypophysectomy, growth hormone, and thyroid-stimulating hormone. Endocrinology 1980; 107: 1291-9
48. 48 Nelson JB, Nguyen SH, Wu-Wong JR et al. New bone formation in an osteoblastic tumor model is increased by endothelin-1 overexpression and decreased by endothelin α receptor blockade. Urology 1999; 53: 1063-9
49. 49 Dahlof B, Gustafsson D, Hedner T et al. Regional haemodynamic effects of endothelin-1 in rat and man: unexpected adverse reactions. J Hypertension 1990; 8: 811-7
50. 50 Davar G, Hans G, Fareed MU et al. Behavioral signs of acute pain produced by application of endothelin-1 to rat sciatic nerve. Neuroreport 1998; 13: 2279-83
51. 51 De-Melo JD, Tonussi CR, D'Orleans-Juste P et al. Articular nociception induced by endothelin-1, carrageenan and LPS in naive and previously inflamed knee-joints in the rat: inhibition by endothelin receptor antagonists. Pain 1998; 77: 261-9
52. A-selective receptor antagonist. J Pharmacol Exp Ther 1996; 276: 473-81